Allakos Debt to Equity Ratio 2018-2018 | ALLK

Current and historical debt to equity ratio values for Allakos (ALLK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Allakos debt/equity for the three months ending June 30, 2018 was 0.00.
Allakos Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-06-30 $0.00B $-0.08B 0.00
2017-12-31 $0.00B $-0.06B 0.00
2017-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.689B $0.000B
Allakos Inc. is a clinical stage bio-technology company. It discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory and proliferative diseases. Allakos Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.247B 15.06
Gilead Sciences (GILD) United States $98.029B 10.88
Biogen (BIIB) United States $68.134B 14.44
Celgene (CELG) United States $59.279B 11.84
Illumina (ILMN) United States $48.357B 60.58
Vertex Pharmaceuticals (VRTX) United States $47.401B 107.84
Regeneron Pharmaceuticals (REGN) United States $43.120B 24.24
Alexion Pharmaceuticals (ALXN) United States $28.735B 21.60
BioMarin Pharmaceutical (BMRN) United States $18.837B 0.00
Incyte (INCY) United States $13.826B 464.57
Seattle Genetics (SGEN) United States $11.846B 0.00
Sarepta Therapeutics (SRPT) United States $9.434B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.180B 0.00
Exact Sciences (EXAS) United States $8.108B 0.00
QIAGEN (QGEN) Netherlands $8.064B 26.37
Bio-Techne Corp (TECH) United States $6.914B 46.24
Bluebird Bio (BLUE) United States $6.866B 0.00
BeiGene (BGNE) Cayman Islands $6.789B 0.00
Alkermes (ALKS) Ireland $6.419B 0.00
Amarin (AMRN) Ireland $6.031B 0.00
Galapagos (GLPG) Belgium $5.305B 0.00
Exelixis (EXEL) United States $5.070B 16.51
Ligand Pharmaceuticals (LGND) United States $4.284B 37.95
Immunomedics (IMMU) United States $4.176B 0.00
GUARDANT HEALTH (GH) United States $3.403B 0.00
Myriad Genetics (MYGN) United States $3.321B 35.28
Ultragenyx Pharmaceutical (RARE) United States $3.314B 0.00
Horizon Pharma Public (HZNP) Ireland $3.213B 18.19
Array BioPharma (ARRY) United States $3.207B 0.00
Emergent Biosolutions (EBS) United States $3.150B 25.09
Blueprint Medicines (BPMC) United States $3.099B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.096B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.049B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.859B 0.00
Ascendis Pharma (ASND) Denmark $2.720B 0.00
Halozyme Therapeutics (HALO) United States $2.587B 34.48
Repligen (RGEN) United States $2.518B 84.53
ARGENX SE-ADR (ARGX) Netherlands $2.518B 0.00
Genomic Health (GHDX) United States $2.450B 136.64
Amicus Therapeutics (FOLD) United States $2.428B 0.00
China Biologic Products (CBPO) China $2.411B 16.57
Acceleron Pharma (XLRN) United States $2.374B 0.00
MyoKardia (MYOK) United States $2.302B 0.00
Medicines (MDCO) United States $2.049B 0.00
Akcea Therapeutics (AKCA) United States $2.038B 0.00
Arena Pharmaceuticals (ARNA) United States $2.031B 0.00
REGENXBIO (RGNX) United States $1.997B 31.38
AnaptysBio (ANAB) United States $1.956B 0.00
Cambrex (CBM) United States $1.946B 15.60
Spark Therapeutics (ONCE) United States $1.907B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.875B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.868B 0.00
Global Blood Therapeutics (GBT) United States $1.866B 0.00
Reata Pharmaceuticals (RETA) United States $1.850B 0.00
Atara Biotherapeutics (ATRA) United States $1.730B 0.00
Aimmune Therapeutics (AIMT) United States $1.689B 0.00
Puma Biotechnology (PBYI) United States $1.668B 0.00
Clovis Oncology (CLVS) United States $1.656B 0.00
Denali Therapeutics (DNLI) United States $1.643B 0.00
Innoviva (INVA) United States $1.567B 10.06
G1 THERAPEUTICS (GTHX) United States $1.564B 0.00
Myovant Sciences (MYOV) United Kingdom $1.504B 0.00
Sangamo Therapeutics (SGMO) United States $1.489B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.447B 0.00
WAVE Life Sciences (WVE) Singapore $1.428B 0.00
Editas Medicine (EDIT) United States $1.409B 0.00
Rubius Therapeutics (RUBY) United States $1.405B 0.00
Mirati Therapeutics (MRTX) United States $1.365B 0.00
Insmed (INSM) United States $1.354B 0.00
IMMURON LTD (IMRN) Australia $1.287B 0.00
Solid Biosciences (SLDB) United States $1.255B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.191B 2273.00
Momenta Pharmaceuticals (MNTA) United States $1.183B 0.00
Cellectis (CLLS) France $1.163B 0.00
NeoGenomics (NEO) United States $1.149B 201.14
DBV Technologies (DBVT) France $1.108B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.090B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.090B 0.00
UniQure (QURE) Netherlands $1.080B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.079B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.072B 0.00
Intellia Therapeutics (NTLA) United States $1.062B 0.00
Intra-Cellular Therapies (ITCI) United States $1.060B 0.00
Audentes Therapeutics (BOLD) United States $1.055B 0.00
Retrophin (RTRX) United States $1.053B 0.00
Lion Biotechnologies (IOVA) United States $1.040B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.987B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.970B 0.00
Athenex (ATNX) United States $0.941B 0.00
Apellis Pharmaceuticals (APLS) United States $0.939B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.938B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.936B 0.00
Revance Therapeutics (RVNC) United States $0.915B 0.00
Acorda Therapeutics (ACOR) United States $0.911B 19.00
Aptinyx (APTX) United States $0.908B 0.00
Viking Therapeutics (VKTX) United States $0.901B 0.00
Coherus BioSciences (CHRS) United States $0.881B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.851B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.806B 0.00
Cara Therapeutics (CARA) United States $0.800B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.791B 0.00
InflaRx (IFRX) Germany $0.787B 0.00
Novavax (NVAX) United States $0.777B 0.00
Fate Therapeutics (FATE) United States $0.774B 0.00
CytomX Therapeutics (CTMX) United States $0.763B 0.00
Heska (HSKA) United States $0.758B 65.25
Dynavax Technologies (DVAX) United States $0.736B 0.00
AVROBIO (AVRO) United States $0.731B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.713B 0.00
Epizyme (EPZM) United States $0.699B 0.00
Mesoblast (MESO) Australia $0.684B 0.00
ANI Pharmaceuticals (ANIP) United States $0.668B 13.22
ObsEva SA (OBSV) Switzerland $0.637B 0.00
AC Immune SA (ACIU) Switzerland $0.631B 0.00
UROGEN PHARMA (URGN) Israel $0.615B 0.00
Kura Oncology (KURA) United States $0.604B 0.00
Anika Therapeutics (ANIK) United States $0.604B 25.40
MiMedx (MDXG) United States $0.588B 25.24
NuCana Sponsored ADR (NCNA) United Kingdom $0.566B 0.00
Arcus Biosciences (RCUS) United States $0.552B 0.00
Principia Biopharma (PRNB) United States $0.546B 0.00
Vericel (VCEL) United States $0.540B 0.00
RA PHARMCTL INC (RARX) United States $0.531B 0.00
UNITY Biotechnology (UBX) $0.522B 0.00
Prothena (PRTA) Ireland $0.519B 0.00
Five Prime Therapeutics (FPRX) United States $0.512B 0.00
Inovio Pharmaceuticals (INO) United States $0.507B 0.00
ARVINAS INC (ARVN) United States $0.506B 0.00
Aduro Biotech (ADRO) United States $0.494B 0.00
Scholar Rock Holding (SRRK) United States $0.483B 0.00
Senesco Technologies (ELOX) United States $0.483B 0.00
Stemline Therapeutics (STML) United States $0.483B 0.00
Abeona Therapeutics (ABEO) United States $0.481B 0.00
MediciNova (MNOV) United States $0.471B 0.00
Cytokineticsorporated (CYTK) United States $0.456B 0.00
Kezar Life Sciences (KZR) United States $0.447B 0.00
Verastem (VSTM) United States $0.444B 0.00
Kindred Biosciences (KIN) United States $0.443B 0.00
Zealand Pharma (ZEAL) Denmark $0.440B 0.00
Liquidia Technologies (LQDA) United States $0.432B 0.00
Zymeworks (ZYME) Canada $0.431B 0.00
BeyondSpring (BYSI) United States $0.431B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.430B 0.00
Sorrento Therapeutics (SRNE) United States $0.427B 73.20
Replimune (REPL) United States $0.423B 0.00
Sinovac Biotech (SVA) China $0.416B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.400B 0.00
UROVANT SCIENCS (UROV) United States $0.387B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.382B 0.00
Merus (MRUS) Netherlands $0.382B 0.00
GRITSTONE ONCLG (GRTS) United States $0.374B 0.00
PDL BioPharma (PDLI) United States $0.374B 5.24
MeiraGTx Holdings (MGTX) United States $0.365B 0.00
Osiris Therapeutics (OSIR) United States $0.362B 0.00
KODIAK SCIENCES (KOD) United States $0.362B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.356B 0.00
ResTORbio (TORC) United States $0.355B 0.00
Albireo Pharma (ALBO) United States $0.346B 0.00
Selecta Biosciences (SELB) United States $0.343B 0.00
Eidos Therapeutics (EIDX) United States $0.340B 0.00
SUTRO BIOPHARMA (STRO) United States $0.329B 0.00
Magenta Therapeutics (MGTA) United States $0.328B 0.00
Kala Pharmaceuticals (KALA) United States $0.328B 0.00
Kadmon Holdings (KDMN) United States $0.325B 0.00
Geron (GERN) United States $0.323B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.321B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.318B 0.00
Adverum Biotechnologies (ADVM) United States $0.316B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.313B 0.00
Evelo Biosciences (EVLO) United States $0.311B 0.00
Axovant Sciences (AXON) United Kingdom $0.309B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.308B 0.00
Cellular Biomedicine (CBMG) United States $0.296B 0.00
MannKind (MNKD) United States $0.295B 0.00
Unum Therapeutics (UMRX) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.293B 0.00
Athersys (ATHX) United States $0.292B 0.00
Seres Therapeutics (MCRB) United States $0.278B 0.00
BioTime (BTX) United States $0.274B 0.00
TOCAGEN INC (TOCA) United States $0.263B 0.00
Celcuity (CELC) United States $0.262B 0.00
Arbutus Biopharma (ABUS) Canada $0.261B 0.00
Celyad SA (CYAD) Belgium $0.261B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.252B 0.00
Synlogic (SYBX) United States $0.251B 0.00
Syros Pharmaceuticals (SYRS) United States $0.250B 0.00
ADMA Biologics Inc (ADMA) United States $0.249B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.245B 0.00
Kamada (KMDA) Israel $0.240B 18.66
ASLAN Pharmaceuticals (ASLN) Singapore $0.239B 0.00
Strongbridge Biopharma (SBBP) United States $0.237B 0.00
Idera Pharmaceuticals (IDRA) United States $0.236B 0.00
Krystal Biotech (KRYS) United States $0.235B 0.00
Agenus (AGEN) United States $0.233B 0.00
NantKwest (NK) United States $0.229B 0.00
BioDelivery Sciences (BDSI) United States $0.223B 0.00
Protagonist Therapeutics (PTGX) United States $0.221B 0.00
Allena Pharmaceuticals (ALNA) United States $0.220B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.211B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.209B 0.00
ChromaDex (CDXC) United States $0.206B 0.00
Mersana Therapeutics (MRSN) United States $0.197B 0.00
Palatin Technologies (PTN) United States $0.191B 7.89
Spring Bank Pharmaceuticals (SBPH) United States $0.190B 0.00
CorMedix Inc (CRMD) United States $0.188B 0.00
Compugen (CGEN) Israel $0.188B 0.00
Cerecor (CERC) United States $0.185B 18.92
Enzo Biochem (ENZ) United States $0.178B 0.00
Clearside Biomedical (CLSD) United States $0.174B 0.00
Constellation Pharmaceuticals (CNST) United States $0.174B 0.00
Cohbar (CWBR) United States $0.173B 0.00
Intec Pharma (NTEC) Israel $0.171B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.170B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.166B 0.00
OVID THERAPEUTC (OVID) United States $0.163B 0.00
Signal Genetics (MGEN) United States $0.162B 0.00
PSivida (EYPT) United States $0.162B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.158B 0.00
Spero Therapeutics (SPRO) United States $0.156B 0.00
VBI Vaccines (VBIV) United States $0.144B 0.00
Cue Biopharma (CUE) United States $0.143B 0.00
Menlo Therapeutics (MNLO) United States $0.142B 0.00
Pfenex (PFNX) United States $0.140B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.140B 0.00
Monster Digital (INNT) United States $0.137B 0.00
Pluristem Therapeutics (PSTI) Israel $0.136B 0.00
XOMA (XOMA) United States $0.134B 14.19
Eleven Biotherapeutics (SESN) United States $0.132B 0.00
Mustang Bio (MBIO) United States $0.130B 0.00
XBiotech (XBIT) United States $0.130B 0.00
VTv Therapeutics (VTVT) United States $0.126B 0.00
Organovo Holdings (ONVO) United States $0.124B 0.00
ITUS (ANIX) United States $0.123B 0.00
Catalyst Biosciences (CBIO) United States $0.122B 0.00
Motif Bio Plc (MTFB) United States $0.120B 0.00
Provention Bio (PRVB) United States $0.119B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
Tapimmune (TPIV) United States $0.114B 0.00
Anavex Life Sciences (AVXL) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.111B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.106B 0.00
Cel-Sci (CVM) United States $0.104B 0.00
Axsome Therapeutics (AXSM) United States $0.103B 0.00
BioXcel Therapeutics (BTAI) United States $0.103B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.101B 0.00
Neothetics (EVFM) United States $0.101B 0.00
Aptevo Therapeutics (APVO) United States $0.099B 0.00
VolitionRX (VNRX) Singapore $0.097B 0.00
Orgenesis (ORGS) United States $0.095B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.094B 0.00
Leap Therapeutics (LPTX) United States $0.094B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Prima BioMed (IMMP) Australia $0.090B 0.00
Checkpoint Therapeutics (CKPT) United States $0.090B 0.00
Cocrystal Pharma (COCP) United States $0.086B 0.00
Ophthotech (OPHT) United States $0.085B 0.55
Protalix BioTherapeutics (PLX) Israel $0.085B 0.00
OncoSec Medical (ONCS) United States $0.083B 0.00
NewLink Genetics (NLNK) United States $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.080B 0.00
Sophiris Bio (SPHS) United States $0.076B 0.00
Alcobra (ARCT) United States $0.075B 0.00
Curis (CRIS) United States $0.075B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.074B 0.00
Celldex Therapeutics (CLDX) United States $0.072B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.071B 0.00
BIONANO GENOMIC (BNGO) United States $0.070B 0.00
Proteostasis Therapeutics (PTI) United States $0.069B 0.00
Evogene (EVGN) Israel $0.069B 0.00
Trevena (TRVN) United States $0.069B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
Fortress Biotech (FBIO) United States $0.062B 0.00
Bellerophon Therapeutics (BLPH) United States $0.059B 0.00
Asterias Biotherapeutics (AST) United States $0.058B 0.00
Oncolytics Biotech (ONCY) Canada $0.056B 0.00
VistaGen Therapeutics (VTGN) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
VIVUS (VVUS) United States $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.048B 0.00
Celsion (CLSN) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
GTx (GTXI) United States $0.043B 0.00
Eyenovia (EYEN) United States $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Galena Biopharma (SLS) United States $0.040B 0.00
Aileron Therapeutics (ALRN) United States $0.038B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.037B 0.00
Advaxis (ADXS) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
BioPharmX (BPMX) United States $0.035B 0.00
Moleculin Biotech (MBRX) United States $0.034B 0.00
Proteon Therapeutics (PRTO) United States $0.032B 0.00
CytRx (CYTR) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
Vical (VICL) United States $0.027B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
OvaScience (OVAS) United States $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Edge Therapeutics (EDGE) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.025B 51.00
Gemphire Therapeutics (GEMP) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.023B 0.00
Arsanis (ASNS) United States $0.022B 0.00
Histogenics (HSGX) United States $0.021B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
RestorGenex (DFFN) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
TrovaGene (TROV) United States $0.019B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 6.49
Adial Pharmaceuticals (ADIL) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Neuralstem (CUR) United States $0.015B 0.00
Oragenics (OGEN) United States $0.015B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Flex Pharma (FLKS) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
AmpliPhi Biosciences (APHB) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00